Global Clinical Trials Speakers
Christopher Gallen, MD, PhD
Dr. Gallen is the Chief Executive Officer of SK biopharmaceuticals. Prior to this, he served as Executive Vice President of Research and Development at Zalicus Inc. from 2010 to 2012. Dr. Gallen served as the President and Chief Executive Officer of Neuromed Pharmaceuticals from July 2004 to December 2009. Prior to joining Neuromed, Dr. Gallen worked for Wyeth Research, beginning in April 2002 and most recently served as its Vice President and Chief of Operations, Clinical Research and Development. Prior to Wyeth, Dr. Gallen was Vice President of Clinical Research at Pharmacia Corporation for three years. From January 1996 to December 1998, Dr. Gallen was the President of the Clinical Research Organization division at Premier Research Worldwide and from 1994 to 1995 he was the Senior Director of Medical and Scientific Services at Quintiles International Clinical Research Corporation. Dr. Gallen holds a BA from the University of Florida, and an MD and PhD from Emory University School of Medicine and trained in psychiatry at Stanford University and neurology at the University of California, San Diego.